PartnerFacts
Data last updated: Oct 23, 2026, 5:45 PM ETLatest filing: Oct 22, 2026Now: Oct 24, 2026, 7:51 AM ET

Sponsor Check › Person

MA
No photo found yet (own website and image search run after this page is viewed)

Michael Aceti

Named as an officer, director or promoter on SEC Form D filings · MA · Jan 9, 2015 → Jun 15, 2026

5deals (issuers)
$310.6Mreported sold
170investors
18Form D filings
2015–2026years on file

Data last updated Oct 23, 2026, 5:45 PM ET · Courts (RECAP) last checked: Oct 24, 2026, 2:15 AM ET · SEC enforcement last checked: covered by the index scan as of Oct 24, 2026, 2:50 AM ET

The short version

Michael Aceti is listed as an executive officer and director on 18 SEC Form D filings by 5 issuers between Jan 2015 and Jun 2026: FOG PHARMACEUTICALS, INC. (Cambridge, MA — pharmaceuticals — 2016; $178M reported sold to 24 investors), ALZHEON, INC. (Framingham, MA — biotechnology — 2015; $126.3M reported sold to 81 investors), TherOptix, Inc. (Needham, MA — industry reported as "Other" — 2021–2023; $5.5M reported sold to 50 investors), Epoch Biotech, LLC (Dover, MA — other technology — 2023–2026; $720K reported sold to 10 investors) and X1 Biotech Inc. (Needham, MA — other technology — 2025–2026; $100K reported sold to 5 investors).

What this means A repeat sponsor — 5 separate companies raised money with this person listed as executive officer and director, over about 11 years. Across those companies the filings report $310.6M sold in total.

Listed alongside Adrienne Graves (5 shared filings), Daniel Kohane (5 shared filings), Richard Lindstrom (5 shared filings), TYLER STOWATER (5 shared filings), Dean Eliott (4 shared filings) and 20 others.

What this means These are the other officers, directors or promoters the companies named on the same forms — the team around Michael. Each name links to their own page.

Public records searched: federal courts (CourtListener / RECAP), SEC enforcement releases, state securities regulators (AK, AL, AR, AZ, CA, CT, DE, FINRA, GA, HI, ID, IL, KS, KY, LA, MA, MD, ME, MI, MO, MS, MT, NASAA, NC, ND, NH, NM, NV, OK, OR, PA, RI, SC, SD, TN, TX, VT, WA, WI, WV, WY) — 3 court cases matching the name, 2 bankruptcy cases matching the name listed in Key records below.

What this means 5 records came back, including 2 court cases still open — open cases can take years and cost money. Each one is listed below with a link to the original document and a line saying why it matched. A name match is not proof it is the same person or company — read the why line and the document. Being sued or named in a release is an accusation, not a finding.

We compared 18 public filings for Michael Aceti and found 11 differences, 2 worth asking the sponsor about: 4 Form Ds were filed more than 15 days after the first sale; Michael Aceti is no longer listed on the Aug 22, 2017 amendment; and more below.

What this means These are differences between the sponsor's own SEC filings — both values, dates and sources are listed in Key records, section 4. Most have ordinary explanations; ask the sponsor.

What the community is saying

Community search for Michael Aceti has not run yet — it is joining a line of 28,373 names; searches run around the clock at the hosts' allowed rate. Searched so far: 638 names.

Community comments are quoted as written by their authors. Sources searched: BiggerPockets forums (via DuckDuckGo, Brave, Bing and BiggerPockets search) and Reddit (search feed + public archive).

Key records

Five things investors ask first. Items still in human review are counted, not shown.

1. Lawsuits

3 cases: 2 open, 1 dismissed

Aceti v. Travelers Home and Marine Insurance Company open
District Court, W.D. New York · No. 1:24-cv-00595 · Filed Jun 25, 2024
Role of Aceti: Plaintiff · Outcome: Open — no termination date on the docket (bulk snapshot 2026-09-30) Docket on CourtListener ↗
same rare surname (3 people in Form D filings, 7 federal dockets); surname only in the caption; court in NY (not a filing state)
ACETI v. JOHNSON & JOHNSON, INC. open
District Court, D. New Jersey · No. 3:19-cv-21786 · Filed Dec 23, 2019 · Nature of suit: 367 Health care / pharm
Role of ACETI: Plaintiff · Outcome: Open — no termination date on the docket (bulk snapshot 2026-09-30) Docket on CourtListener ↗
same rare surname (3 people in Form D filings, 7 federal dockets); surname only in the caption; court in NJ (not a filing state)
Aceti v. Bank of America Corporation dismissed
District Court, S.D. Florida · No. 1:09-cv-22336 · Filed Aug 7, 2009 · Closed May 28, 2010 · Nature of suit: 290 Other real property actions
Role of Aceti: Plaintiff · Outcome: Terminated 2010-05-28 — FJC Integrated Database disposition: Voluntarily dismissed Docket on CourtListener ↗
same rare surname (3 people in Form D filings, 7 federal dockets); surname only in the caption; court in FL (not a filing state)
What was searched

Sources searched: CourtListener bulk data (RECAP dockets as of 2026-09-30; recall-first rule 10-24) — federal district + bankruptcy courts State courts: not covered (one-tap state court links under Look further). PACER: not searched. · Last checked Oct 24, 2026, 2:15 AM ET.

Court records show docket facts only; we never restate allegations as facts. Outcome wording comes from the docket feed; where it does not state a disposition we say so.

State courts: not covered (one-tap state court links under Look further). No state offers a lawful automated statewide source PartnerFacts can use today. Texas (re:SearchTX) terms prohibit storing results in a database open to third parties; New York (WebCivil) and Massachusetts (MassCourts) require a browser check that blocks scripted queries; California has no statewide index (58 county portals; Rule of Court 2.503 grants name-based access case by case); Florida, Utah and Illinois offer paid or partial access whose terms for automated use are unverified. Washington (dw.courts.wa.gov; bulk index reports under a JISC data-dissemination agreement), Delaware (CourtConnect; Court of Chancery not included) and Arizona (apps.azcourts.gov/publicaccess, which has an official channel to request high-volume access) are the candidates; PartnerFacts will request written permission before any automated search. Federal courts are searched through CourtListener / RECAP.

2. Regulatory actions

None found in sources searched — SEC enforcement releases (index scan as of Oct 24, 2026, 2:50 AM ET) · state securities regulators: VA (crawled Oct 23, 2026)

What was searched

SEC enforcement searched: SEC litigation releases and administrative proceedings — respondent names in the sec.gov index titles (30,205 releases, 1995-09-19 to 2026-10-23); release text is read only to confirm a candidate. Names that appear only in the body of a release are not found. — Searched SEC litigation releases and administrative proceedings (1995→ / 2007→) (30,205 records as of Oct 24, 2026, 2:50 AM ET) — nothing matched Michael Aceti..

State securities regulators: Securities regulators searched (3,318 actions): AZ Corporation Commission Securities Division (411 actions, 2017–2026), CA DFPI (25 actions, 2007–2024; listing starts 2002 — 16 of 12,159 DFPI respondent pages read so far; sponsor-name matches are read first), DE DOJ Investor Protection Unit (257 actions, 1987–2026), TX State Securities Board (586 actions, 2006–2026), WA DFI (2,039 actions, 2001–2026) — last crawled Oct 23, 2026, 9:57 PM ET. No machine-readable public listing today for CO, FL, IA, IN, MN, NE, NJ, NY, OH, UT, VA (see docs/state-regulators.md).

3. Bankruptcies

2 cases: 2 closed (disposition not in docket feed)

John R Aceti and Renna G Aceti closed
United States Bankruptcy Court, C.D. California · No. 9:10-bk-12984 · Filed Jun 15, 2010 · Closed Oct 28, 2010
Role of John R Aceti and Renna G Aceti: Debtor · Outcome: Case closed 2010-10-28 (disposition not included in the bulk docket feed — see docket) Docket on CourtListener ↗
same rare surname (3 people in Form D filings, 7 federal dockets); different first name (john); court in CA (not a filing state)
Michael Joseph Aceti and Panee Aceti closed
United States Bankruptcy Court, W.D. North Carolina · No. 10-30112 · Filed Jan 20, 2010 · Closed Jul 30, 2010
Role of Michael Joseph Aceti and Panee Aceti: Debtor · Outcome: Case closed 2010-07-30 (disposition not included in the bulk docket feed — see docket) Docket on CourtListener ↗
same rare surname (3 people in Form D filings, 7 federal dockets); different first name (joseph); court in NC (not a filing state)
What was searched

Sources searched: Federal bankruptcy courts via CourtListener / RECAP archive (federal district courts, federal bankruptcy courts). State courts: not covered (one-tap state court links under Look further). PACER: not searched (RECAP only). · Last checked Oct 24, 2026, 2:15 AM ET.

Court records show docket facts only; we never restate allegations as facts. Outcome wording comes from the docket feed; where it does not state a disposition we say so.

State courts: not covered (one-tap state court links under Look further). No state offers a lawful automated statewide source PartnerFacts can use today. Texas (re:SearchTX) terms prohibit storing results in a database open to third parties; New York (WebCivil) and Massachusetts (MassCourts) require a browser check that blocks scripted queries; California has no statewide index (58 county portals; Rule of Court 2.503 grants name-based access case by case); Florida, Utah and Illinois offer paid or partial access whose terms for automated use are unverified. Washington (dw.courts.wa.gov; bulk index reports under a JISC data-dissemination agreement), Delaware (CourtConnect; Court of Chancery not included) and Arizona (apps.azcourts.gov/publicaccess, which has an official channel to request high-volume access) are the candidates; PartnerFacts will request written permission before any automated search. Federal courts are searched through CourtListener / RECAP.

4. Differences between public sources

Comparisons cover issuers and sponsor groups — see the issuer pages under Deals

11 differences found between the filings for Michael Aceti — 2 worth asking about (compared 18 filings on Oct 24, 2026)

Note · Aug 7, 2009 – Jun 25, 2024

3 court cases name Michael Aceti

By role: plaintiff in 3. Newest: "Aceti v. Travelers Home and Marine Insurance Company" (District Court, W.D. New York, Jun 25, 2024); "ACETI v. JOHNSON & JOHNSON, INC." (District Court, D. New Jersey, Dec 23, 2019); "Aceti v. Bank of America Corporation" (District Court, S.D. Florida, Aug 7, 2009). Some of these are name matches with a match estimate below 95% — check each docket.

What this means Several court cases name this subject. Some are routine business suits. Ask what each was about and how it ended.

Sources
Note · Jun 7, 2016

15% of the money raised went to insiders — FOG PHARMACEUTICALS, INC.

The Jun 7, 2016 Form D reports $7,425,915 sold and $1,100,000 of the proceeds used for payments to officers, directors or promoters (marked as an estimate).

What this means The filing reports how much of the money raised was paid to insiders. Over 10% is high for most deals. Ask what it paid for.

Sources
Worth asking · Mar 19, 2023 – Jun 15, 2026

4 Form Ds were filed more than 15 days after the first sale

Form D filed 561 days after the first sale — X1 Biotech Inc. · Form D filed 115 days after the first sale — Epoch Biotech, LLC · Form D filed 26 days after the first sale — X1 Biotech Inc. · Form D filed 35 days after the first sale — Epoch Biotech, LLC

What this means Late notices are common and carry no penalty by themselves. A pattern of late paperwork is worth asking the sponsor about.

Sources
Note · Dec 30, 2014 – May 21, 2025

5 offerings have no amendment in the last 12 months and may still be open

No amendment in the last 12 months on an offering that may still be open — X1 Biotech Inc. (latest filing May 21, 2025) · No amendment in the last 12 months on an offering that may still be open — Epoch Biotech, LLC (latest filing Jul 18, 2024) · No amendment in the last 12 months on an offering that may still be open — Epoch Biotech, LLC (latest filing Jul 12, 2023) · No amendment in the last 12 months on an offering that may still be open — TherOptix, Inc. (latest filing Jun 12, 2023) · No amendment in the last 12 months on an offering that may still be open — ALZHEON, INC. (latest filing Feb 25, 2015)

What this means SEC rules expect a yearly amendment while an offering is still going. Ask the sponsor which of these raises have closed.

Sources
Worth asking · Jun 7, 2016 – Aug 22, 2017

Michael Aceti is no longer listed on the Aug 22, 2017 amendment — FOG PHARMACEUTICALS, INC.

Michael Aceti appears on the Jun 7, 2016 Form D (executive officer) but not on the Aug 22, 2017 Form D/A for the same offering.

What this means People leave, and the issuer must list only current officers, directors and promoters. It is still worth asking why this person left and who replaced them.

Sources
Note · Jun 7, 2016 – Jan 14, 2026

7 offerings changed their target amount between filings

Offering amount changed between filings — Epoch Biotech, LLC · Offering amount changed between filings — X1 Biotech Inc. · Offering amount changed between filings — Epoch Biotech, LLC · Offering amount changed between filings — TherOptix, Inc. · Offering amount changed between filings — TherOptix, Inc. · and 2 more

What this means Targets change as deals grow or shrink. Ask whether later money has the same terms.

Sources
Note · Jan 9, 2015 – Jul 18, 2024

Michael Aceti is written 2 different ways on the filings

listed as "Michael Aceti" on 14 filings (from Jan 9, 2015), and "Michael R. Aceti" on 4 filings (from Jul 18, 2024).

What this means Same person, written differently — a middle name or suffix left off, or spelled another way. It is normal, but check that the full legal name matches your subscription documents.

Sources
Note · Jul 12, 2023 – Jul 18, 2024

Industry group changed between filings — Epoch Biotech, LLC

"Biotechnology" (Jul 12, 2023); then "Other Technology" (Jul 18, 2024 to Jan 14, 2026).

What this means The issuer described its business differently on different forms. Often it is just a different box ticked; sometimes the deal itself changed. Ask which business your money is in.

Sources
Note · Jun 8, 2021 – Sep 26, 2022

Address moved from Wapole, MA to Needham, MA — TherOptix, Inc.

The people listed on the Jun 8, 2021 filing give Wapole, MA; on the Sep 26, 2022 filing they give Needham, MA.

What this means Businesses move; this just shows the two places and dates. If you were told one city and the forms say another, ask which is current.

Sources
Note · Dec 11, 2019 – Jun 8, 2021

Address moved from San Francisco, CA to Wapole, MA — TherOptix, Inc.

The people listed on the Dec 11, 2019 filing give San Francisco, CA; on the Jun 8, 2021 filing they give Wapole, MA.

What this means Businesses move; this just shows the two places and dates. If you were told one city and the forms say another, ask which is current.

Sources
Note · Jun 7, 2016 – Aug 22, 2017

Address moved from Boston, MA to Cambridge, MA — FOG PHARMACEUTICALS, INC.

The people listed on the Jun 7, 2016 filing give Boston, MA; on the Aug 22, 2017 filing they give Cambridge, MA.

What this means Businesses move; this just shows the two places and dates. If you were told one city and the forms say another, ask which is current.

Sources
What is compared

What is compared: every Form D and D/A we hold for this subject, side by side — filing dates vs. first-sale dates (the 15-day rule), amendment timing on open offerings (the yearly-amendment expectation), amounts sold, investor counts, offering amounts and minimums across amendments, industry and size bands, addresses, how each person's name and role is written, paid sellers' CRD numbers, and (for groups) where the member companies were formed and sit. Everything is as filed by the issuer; the SEC does not check it. Differences are common and usually have ordinary explanations — we show both values, the dates, and the source so you can ask. As of Oct 24, 2026.

5. Money to insiders

2 of 10 offerings report sales commissions totalling $1,122,344; 0 report finder's fees; 1 reports proceeds to related persons totalling $1,100,000. (includes amounts the issuer reported as estimates)

Offering (latest filing)Sales commissionsFinder's feesTo insidersPaid to sell itSource
Jun 15, 2026 D
X1 Biotech Inc.
File 021-587359
$0$0$0None listed on this filingEDGAR ↗
Jan 14, 2026 D/A
Epoch Biotech, LLC
File 021-550019
$0$0$0None listed on this filingEDGAR ↗
Dec 11, 2025 D/A
X1 Biotech Inc.
File 021-546824
$0$0$0 (est.)None listed on this filingEDGAR ↗
May 21, 2025 D
X1 Biotech Inc.
File 021-546821
$0$0$0 (est.)None listed on this filingEDGAR ↗
Jul 18, 2024 D
Epoch Biotech, LLC
File 021-519110
$0$0$0 (est.)None listed on this filingEDGAR ↗
Jul 12, 2023 D
Epoch Biotech, LLC
File 021-486632
$0$0$0None listed on this filingEDGAR ↗
Jun 12, 2023 D/A
TherOptix, Inc.
File 021-350161
$0$0$0None listed on this filingEDGAR ↗
Jun 7, 2016 D
FOG PHARMACEUTICALS, INC.
File 021-264481
$0$0$1,100,000 (est.)None listed on this filingEDGAR ↗
Jul 27, 2015 D
ALZHEON, INC.
File 021-244477
$402,344$0$0Brookline Group, LLC BrokerCheck CRD 153587 ↗EDGAR ↗
Feb 25, 2015 D/A
ALZHEON, INC.
File 021-231832
$720,000 (est.)$0$0
The Company shall use some of the offering proceeds to pay salaries to executive officers in the ordinary course of business but shall not make any transaction based payments in connection with the offering.
Brookline Group, LLC BrokerCheck CRD 153587 ↗EDGAR ↗
How this is counted

Counts come from Form D Items 12–15 on the filings in our index (latest filing per offering; one offering = one SEC file number; an amendment updates its offering rather than adding one). "To insiders" = gross proceeds used for payments to executive officers, directors or promoters. "—" = not reported on that filing. Amounts marked (est.) were reported as estimates. "Paid to sell it" = sales compensation recipients named on that filing (Item 12), each linked to FINRA BrokerCheck when a CRD number is reported.

Counted across every filing this person is listed on (latest filing per offering, per issuer).

Deals 5

Every issuer that named Michael Aceti on a Form D, newest first. A Form D is the notice a company files after it starts selling a private investment.

Other Technology

X1 Biotech Inc.

Needham, MA · May 21, 2025 → Jun 15, 2026 · 4 filings
  • Jun 15, 2026 · D · $40,000 sold of $2,000,000 · 2 investors · min. No minimum reported · role: Executive Officer EDGAR ↗
  • Dec 11, 2025 · D/A · $95,000 sold of $300,000 · 5 investors · min. No minimum reported · role: Executive Officer EDGAR ↗
  • May 21, 2025 · D · $95,000 sold of $200,000 · 5 investors · min. No minimum reported · role: Executive Officer EDGAR ↗
  • May 21, 2025 · D · $100,000 sold of $2,000,000 · 1 investors · min. No minimum reported · role: Executive Officer EDGAR ↗

Raised $100K from 5 investors (5% of the $2M target) as of the latest filing. Michael is listed as executive officer on 4 filings for this deal.

Sources

Every row is a Form D or D/A on which the issuer listed this name as a related person. Amount sold and investors are the maximum reported on any filing for this issuer. "Similar" = offerings in the same industry claiming the same exemption, filed in the last 5 years: Other Technology / 506(b) (17,390 filings); ranges are the middle half (25th–75th percentile). Computed by PartnerFacts from SEC EDGAR Form D data as of Oct 23, 2026, 5:45 PM ET. Rows without a range: fewer than 30 comparable filings, or not a Rule 506 offering. No ranking or score.

Other Technology

Epoch Biotech, LLC

Dover, MA · Jul 12, 2023 → Jan 14, 2026 · 5 filings
  • Jan 14, 2026 · D/A · $300,000 sold of $1,700,000 · 5 investors · min. No minimum reported · role: Executive Officer, Director EDGAR ↗
  • Nov 3, 2025 · D/A · $240,000 sold of $240,000 · 4 investors · min. No minimum reported · role: Executive Officer, Director EDGAR ↗
  • Jun 26, 2025 · D · $140,000 sold of $140,000 · 3 investors · min. No minimum reported · role: Executive Officer, Director EDGAR ↗
  • Jul 18, 2024 · D · $40,000 sold of $620,000 · 2 investors · min. No minimum reported · role: Executive Officer, Director (Director/Manager) EDGAR ↗
  • Jul 12, 2023 · D · $720,000 sold of $1,500,000 · 10 investors · min. No minimum reported · role: Executive Officer, Director EDGAR ↗

Raised $720K from 10 investors (42% of the $1.7M target) as of the latest filing. Michael is listed as executive officer, director on 5 filings for this deal.

Sources

Every row is a Form D or D/A on which the issuer listed this name as a related person. Amount sold and investors are the maximum reported on any filing for this issuer. "Similar" = offerings in the same industry claiming the same exemption, filed in the last 5 years: Other Technology / 506(b) (17,390 filings); ranges are the middle half (25th–75th percentile). Computed by PartnerFacts from SEC EDGAR Form D data as of Oct 23, 2026, 5:45 PM ET. Rows without a range: fewer than 30 comparable filings, or not a Rule 506 offering. No ranking or score.

Other

TherOptix, Inc.

Needham, MA · Jun 8, 2021 → Jun 12, 2023 · 5 filings
  • Jun 12, 2023 · D/A · $5,499,444 sold of $5,500,000 · 50 investors · min. No minimum reported · role: Executive Officer EDGAR ↗
  • Feb 7, 2023 · D/A · $4,029,444 sold of $4,500,000 · 38 investors · min. No minimum reported · role: Executive Officer EDGAR ↗
  • Dec 1, 2022 · D/A · $3,804,444 sold of $4,500,000 · 36 investors · min. No minimum reported · role: Executive Officer EDGAR ↗
  • Sep 26, 2022 · D/A · $3,724,444 sold of $4,500,000 · 35 investors · min. No minimum reported · role: Executive Officer EDGAR ↗
  • Jun 8, 2021 · D/A · $3,499,444 sold of $3,500,000 · 29 investors · min. No minimum reported · role: Executive Officer EDGAR ↗

Raised $5.5M from 50 investors (100% of the $5.5M target) as of the latest filing. Michael is listed as executive officer on 5 filings for this deal.

Sources

Every row is a Form D or D/A on which the issuer listed this name as a related person. Amount sold and investors are the maximum reported on any filing for this issuer. "Similar" = offerings in the same industry claiming the same exemption, filed in the last 5 years: Other / 506(b) (18,678 filings); ranges are the middle half (25th–75th percentile). Computed by PartnerFacts from SEC EDGAR Form D data as of Oct 23, 2026, 5:45 PM ET. Rows without a range: fewer than 30 comparable filings, or not a Rule 506 offering. No ranking or score.

Pharmaceuticals

FOG PHARMACEUTICALS, INC.

Cambridge, MA · Jun 7, 2016
  • Jun 7, 2016 · D · $7,425,915 sold of $10,000,000 · 11 investors · min. No minimum reported · role: Executive Officer EDGAR ↗

Raised $178M from 24 investors (100% of the $10M target) as of the latest filing. Michael is listed as executive officer.

Sources

Every row is a Form D or D/A on which the issuer listed this name as a related person. Amount sold and investors are the maximum reported on any filing for this issuer. "Similar" = offerings in the same industry claiming the same exemption, filed in the last 5 years: Pharmaceuticals / 506(b) (800 filings); ranges are the middle half (25th–75th percentile). Computed by PartnerFacts from SEC EDGAR Form D data as of Oct 23, 2026, 5:45 PM ET. Rows without a range: fewer than 30 comparable filings, or not a Rule 506 offering. No ranking or score.

Biotechnology

ALZHEON, INC.

Framingham, MA · Jan 9, 2015 → Jul 27, 2015 · 3 filings
  • Jul 27, 2015 · D · $6,905,000 sold of $6,905,000 · 26 investors · min. No minimum reported · role: Executive Officer EDGAR ↗
  • Feb 25, 2015 · D/A · $7,344,629 sold of Indefinite · 60 investors · min. No minimum reported · role: Executive Officer EDGAR ↗
  • Jan 9, 2015 · D · $3,050,000 sold of Indefinite · 12 investors · min. No minimum reported · role: Executive Officer EDGAR ↗

Raised $126.3M from 81 investors (100% of the $6.91M target) as of the latest filing. Michael is listed as executive officer on 3 filings for this deal.

Sources

Every row is a Form D or D/A on which the issuer listed this name as a related person. Amount sold and investors are the maximum reported on any filing for this issuer. "Similar" = offerings in the same industry claiming the same exemption, filed in the last 5 years: Biotechnology / 506(b) (3,253 filings); ranges are the middle half (25th–75th percentile). Computed by PartnerFacts from SEC EDGAR Form D data as of Oct 23, 2026, 5:45 PM ET. Rows without a range: fewer than 30 comparable filings, or not a Rule 506 offering. No ranking or score.

People around Michael 25

Officers, directors, promoters and management entities named on the same filings, as of Oct 23, 2026, 5:45 PM ET.

TS
No photo found yet (own website and image search run after this page is viewed)
Person

TYLER STOWATER

Director · 5 shared filings (1 issuer) · also on 33 other issuers

TYLER STOWATER is on 34 issuers in total — a repeat sponsor. Their page lists every one.

DK
No photo found yet (own website and image search run after this page is viewed)
Person

Daniel Kohane

Director · 5 shared filings (1 issuer)

Listed on the same filings as Michael Aceti. Their page shows their other deals.

AG
No photo found yet (own website and image search run after this page is viewed)
Person

Adrienne Graves

Director · 5 shared filings (1 issuer) · also on 5 other issuers

Adrienne Graves is on 6 issuers in total — a repeat sponsor. Their page lists every one.

RL
No photo found yet (own website and image search run after this page is viewed)
Person

Richard Lindstrom

Director · 5 shared filings (1 issuer) · also on 16 other issuers

Richard Lindstrom is on 17 issuers in total — a repeat sponsor. Their page lists every one.

LK
No photo found yet (own website and image search run after this page is viewed)
Person

Leo Kim

Director · 4 shared filings (1 issuer)

Listed on the same filings as Michael Aceti. Their page shows their other deals.

LK
No photo found yet (own website and image search run after this page is viewed)
Person

Lawrence Kaufman

Executive Officer · 4 shared filings (1 issuer)

Listed on the same filings as Michael Aceti. Their page shows their other deals.

DE
No photo found yet (own website and image search run after this page is viewed)
Person

Dean Eliott

Director · 4 shared filings (1 issuer) · also on 1 other issuer

Listed on the same filings as Michael Aceti. Their page shows their other deals.

MM
No photo found yet (own website and image search run after this page is viewed)
Person

Monty Montoya

Executive Officer, Director · 4 shared filings (1 issuer) · also on 1 other issuer

Listed on the same filings as Michael Aceti. Their page shows their other deals.

JC
No photo found yet (own website and image search run after this page is viewed)
Person

Joseph Ciolino

Director · 4 shared filings (1 issuer)

Listed on the same filings as Michael Aceti. Their page shows their other deals.

JV
No photo found yet (own website and image search run after this page is viewed)
Person

Joseph Arboleda-Valasquez

Director · 3 shared filings (1 issuer)

Listed on the same filings as Michael Aceti. Their page shows their other deals.

SM
No photo found yet (own website and image search run after this page is viewed)
Person

Scott Minick

Director · 3 shared filings (1 issuer) · also on 2 other issuers

Listed on the same filings as Michael Aceti. Their page shows their other deals.

MT
No photo found yet (own website and image search run after this page is viewed)
Person

MARTIN TOLAR

Executive Officer, Director · 3 shared filings (1 issuer) · also on 1 other issuer

Listed on the same filings as Michael Aceti. Their page shows their other deals.

FH
No photo found yet (own website and image search run after this page is viewed)
Person

Franz Hefti

Director · 3 shared filings (1 issuer) · also on 1 other issuer

Listed on the same filings as Michael Aceti. Their page shows their other deals.

JS
No photo found yet (own website and image search run after this page is viewed)
Person

Jean-Pierre Sommadossi

Director · 3 shared filings (1 issuer) · also on 3 other issuers

Listed on the same filings as Michael Aceti. Their page shows their other deals.

JH
No photo found yet (own website and image search run after this page is viewed)
Person

John Hey

Executive Officer · 3 shared filings (1 issuer)

Listed on the same filings as Michael Aceti. Their page shows their other deals.

DN
No photo found yet (own website and image search run after this page is viewed)
Person

David Nikodem

Director · 3 shared filings (1 issuer)

Listed on the same filings as Michael Aceti. Their page shows their other deals.

MB
No photo found yet (own website and image search run after this page is viewed)
Person

Menghis Bairu

Director · 3 shared filings (1 issuer)

Listed on the same filings as Michael Aceti. Their page shows their other deals.

FB
No photo found yet (own website and image search run after this page is viewed)
Person

Franklin Berger

Director · 3 shared filings (1 issuer) · also on 12 other issuers

Franklin Berger is on 13 issuers in total — a repeat sponsor. Their page lists every one.

GV
No photo found yet (own website and image search run after this page is viewed)
Person

Gregory L. Verdine

Executive Officer, Director · 1 shared filing (1 issuer) · also on 1 other issuer

Listed on the same filings as Michael Aceti. Their page shows their other deals.

MV
No photo found yet (own website and image search run after this page is viewed)
Person

MARK VERSAVEL

Executive Officer · 1 shared filing (1 issuer)

Listed on the same filings as Michael Aceti. Their page shows their other deals.

RS
No photo found yet (own website and image search run after this page is viewed)
Person

Robert Silverman

Executive Officer · 1 shared filing (1 issuer)

Listed on the same filings as Michael Aceti. Their page shows their other deals.

WZ
No photo found yet (own website and image search run after this page is viewed)
Person

WeiQing Zhou

Executive Officer · 1 shared filing (1 issuer) · also on 1 other issuer

Listed on the same filings as Michael Aceti. Their page shows their other deals.

AS
No photo found yet (own website and image search run after this page is viewed)
Person

Amir Shojaei

Executive Officer, Director · 1 shared filing (1 issuer)

Listed on the same filings as Michael Aceti. Their page shows their other deals.

NC
No photo found yet (own website and image search run after this page is viewed)
Person

Neal Chen

Director · 1 shared filing (1 issuer)

Listed on the same filings as Michael Aceti. Their page shows their other deals.

JV
No photo found yet (own website and image search run after this page is viewed)
Person

Joseph Arboleda-Velasquez

Director · 1 shared filing (1 issuer)

Listed on the same filings as Michael Aceti. Their page shows their other deals.

The team behind the deals

Same business address

2 other issuers file from the same address

A shared address can mean the same team, a shared office building or a registered agent. It is a lead, not a conclusion.

Registrations and other filings

Adviser registration (Form ADV)

None of the 5 issuers this person is listed on appears in Form ADV (searched 24,962 advisers as of Oct 2, 2026). A person is never an adviser firm; Form ADV is checked for the issuers and the management companies they are listed with.

Other offering types (Regulation A and Regulation Crowdfunding)

Searched SEC Regulation A Data Sets (Forms 1-A, 1-K, 1-Z; 2015 Q2 → 2026 Q3); SEC Crowdfunding Offerings Data Sets (Form C family; 2016 Q2 → 2026 Q3); EDGAR form index for 2026 Q3 → 2026 Q4 (51,358 records as of Oct 23, 2026, 8:41 PM ET) — nothing matched this name.

Property records none — individuals are not matched

Property records are matched to companies only, never to individuals, so none are matched to Michael Aceti by design. Searched property records in Hillsborough County FL (Clerk recorded-document index Oct 14, 2026 to Oct 15, 2026 + FL DOR 2026 ownership roll), Miami-Dade County FL (FL DOR 2026 ownership roll), Harris County TX (HCAD 2026 ownership roll), Dallas County TX (DCAD 2026 ownership roll), New York City ACRIS documents and PLUTO ownership rows already retrieved for other issuers, Cook County IL sale and ownership rows already retrieved for other issuers (814,874 records as of Oct 23, 2026, 8:59 PM ET) for the 5 issuers this person is listed on — nothing matched.

Public profiles and social

Websites and social links of the issuers Michael Aceti is listed on: none on file. No website or social profile named in FOG PHARMACEUTICALS, INC.'s SEC filings (Form C, Reg A, Form ADV; checked Oct 24, 2026). Web search for this name: #138,472 of 374,652 in line (1,346 issuers searched so far). One-tap searches: Look further ↓

Look further

One-tap searches on sites we do not index ourselves, with the name pre-filled (Cambridge, MA). Each opens in a new tab; what you find there is not verified by PartnerFacts.

Change history

No corrections have been requested for this page.

Every fact links to its public-record source. Plain-English notes next to a fact are our reading of that fact, not a rating. Request a correction · Facts policy

Request a correction

Free. Logged with status: received → under review → fixed / confirmed with source.

Add a response

If this is you or your firm, add a sourced explanation next to any fact. Reviewed before publishing.

Monitor this person

Members get an email when Michael Aceti appears on a new Form D, or when a court case or SEC action is matched to them. See plans →